The MuliJector is aimed at processors looking to increase throughput, broaden their product range or update equipment to ...
Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results